Olaratumab (Anti-PDGFRA / CD140a)

Synonyms: IMC-3G3, LY3012207

Olaratumab (IMC-3G3; LY3012207) is a fully human IgG1 monoclonal antibody directed against the platelet-derived growth factor receptor alpha (PDGFR alpha) with potential antineoplastic activity. MW: 145.5 kD.

Olaratumab (Anti-PDGFRA / CD140a)

Selleck's Olaratumab (Anti-PDGFRA / CD140a) has been cited by 1 publication

Purity & Quality Control

Batch: Purity: 99% Protein concentration: 10.355mg/ml Endotoxin Level: <1EU/mg
99

Choose Selective PDGFR Inhibitors

Name Citation PDGFR PDGFRα PDGFRβ Others
Dovitinib (TKI-258) 51 FLT3,c-Kit,VEGFR3/FLT4
Linifanib (ABT-869) 33 VEGFR1/FLT1,CSF-1R,VEGFR2/KDR
Crenolanib 96
Masitinib 41 Kit,Lyn B,Abl1
Amuvatinib (MP-470) 20 c-Kit (D816H),FLT3 (D835Y)
Motesanib Diphosphate (AMG-706) 12 VEGFR1,VEGFR2,VEGFR2/Flk1
Orantinib (SU6668) 20
CP-673451 35
Ki8751 20 VEGFR2,c-Kit
Telatinib 5 c-Kit,VEGFR3,VEGFR2
PP121 5 Hck,VEGFR,mTOR
MK-2461 4 c-Met (M1250T),c-Met (Y1235D),c-Met (Y1230H)
Tyrphostin AG 1296 14 c-Kit (Swiss 3T3),FGFR (Swiss 3T3)
Tyrphostin 9 1 EGFR
Dovitinib (TKI258) Lactate monohydrate 31 FLT3,c-Kit,FGFR1
AZD2932 3 Flt3,VEGFR-2,c-Kit
Sennoside B
Expand to Check More
1. "+" indicates inhibitory effect. Increased inhibition is marked by a higher "+" designation. 2. "✔" indicates inhibitory effect, but without specific value.

Biological Activity

Description Olaratumab (IMC-3G3; LY3012207) is a fully human IgG1 monoclonal antibody directed against the platelet-derived growth factor receptor alpha (PDGFR alpha) with potential antineoplastic activity. MW: 145.5 kD.

Product Details

CAS No. 1024603-93-7
Molecular Weight 145.5 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac,pH5.0
Storage
(From the date of receipt)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Olaratumab (Anti-PDGFRA / CD140a) | Olaratumab (Anti-PDGFRA / CD140a) supplier | purchase Olaratumab (Anti-PDGFRA / CD140a) | Olaratumab (Anti-PDGFRA / CD140a) cost | Olaratumab (Anti-PDGFRA / CD140a) manufacturer | order Olaratumab (Anti-PDGFRA / CD140a) | Olaratumab (Anti-PDGFRA / CD140a) distributor